Introduction
============

*Vibrio cholerae*, a Gram-negative and curved bacterium, is the causative agent of the diarrheal disease cholera ([@B6]). This pathogen expresses various key virulence factors, including major ones, such as cholera toxin (CT), toxin co-regulated pilus (TCP), flagellum, and cholera hemolysin (HlyA; [@B1]; [@B3]; [@B6]). HlyA, an extracellular pore-forming toxin, is expressed in the El Tor biotype and most of the non-O1/non-O139 isolates ([@B55]; [@B41]; [@B11]). It possesses various biological activities including hemolytic activity, lethality, cardiotoxicity, cytotoxicity, and enterotoxicity ([@B21]; [@B3]). HlyA has been recognized as a virulence determinant in the infant mouse cholera model ([@B13]). Purified HlyA can induce fluid accumulation and a histological change in the mucosa when injected into rabbit ileal loops ([@B21]; [@B10]). *In vitro* studies showed that HlyA induces cell vacuolation and apoptosis in cultured mammalian cells ([@B7]; [@B32]; [@B14]; [@B4]). HlyA was also strongly suggested to be responsible for lethality, developmental delay, and intestinal vacuoles formation in *Caenorhabditis elegans* during *V. cholerae* infection ([@B5]; [@B39]).

Expression of HlyA was highly induced when *V. cholerae* was cultured in rabbit ileal loops ([@B53]). It has also been found to be positively regulated by HlyU, a member of SmtB/ArsR family of transcriptional repressors ([@B38]). Deletion of *hlyU* decreased HlyA production but increased LD~50~ in the infant mouse cholera model ([@B50]). HlyU acts as a dimer that binds to the promoter of *hlyA* to activate its transcription ([@B33]). In addition, the quorum sensing (QS) master regulator HapR was shown to be involved in repressing HlyA expression at both the transcriptional and posttranscriptional levels ([@B45]). Repression of *hlyA* by HapR at the transcriptional level was achieved through direct binding of HapR to the *hlyA* promoter, while that at posttranscriptional level was mediated via the metalloprotease HapA ([@B45]). However, as a virulence factor, expression of *hlyA* should be under the tight control of multiple regulators.

The ferric uptake regulator Fur is a metal-dependent DNA-binding protein that regulates multiple genes related to metabolism and virulence in *V. cholerae* ([@B35]; [@B9]; [@B31]; [@B52]; [@B8]). A 19 bp palindromic sequence was previously described as the DNA binding box of Fur in *V. cholerae* ([@B18]). However, the palindromic sequence cannot explain all of the DNA-binding characteristics of Fur. Thus, an enhanced *V. cholerae* Fur box with a 21 bp palindromic sequence was constructed based on the ChIP-seq-identified binding sites, but it shares an identical span of bases with the previously predicted ([@B8]). One Fur box-like sequence, TGAATATCAGTAATTGTTATT, was found within the upstream DNA region of *hlyA*, suggesting that its transcription might be under the direct control of Fur. In the present study, we showed that the highest transcription of *hlyA* occurs at early mid-logarithmic growth phase due to the collective and elaborate regulation of HapR, Fur, and HlyU, suggesting that HlyA would only function during the early mid-logarithmic growth phase in *V. cholerae*. The complex regulatory actions of HapR, Fur, and HlyU on *hlyA* transcription would be beneficial to the invasion and pathogenesis of *V. cholerae*.

Materials and Methods {#s1}
=====================

Construction of the Mutants and Complementary Mutants
-----------------------------------------------------

*Vibrio cholerae* O1 El Tor strain C7258 (Peru, 1991) was used as the wild type (WT) in this study. The deletion mutants of *hapR, fur*, and *hlyU* (designated as *ΔhapR, Δfur*, and *ΔhlyU*, respectively) were constructed from WT using the suicide plasmid pWM91 by allelic exchange, which was similarly performed as previously described ([@B51]). To construct the complementary mutants, the entire coding region of each deleted gene was cloned into the pBAD24 vector harboring an arabinose PBAD promoter and an ampicillin resistance gene ([@B19]; [@B43]). After being verified by DNA sequencing, the complementary plasmid for each deleted gene was transferred into the corresponding mutant, yielding the complementary mutant strain *ΔhapR*/pBAD24-*hapR, Δfur*/pBAD24-*fur*, or *ΔhlyU*/pBAD24-*hlyU*. In order to counteract the effects of arabinose and ampicillin on bacterial growth, the empty vector pBAD24 was introduced into WT or each mutant to generate WT/pBAD24, *ΔhapR*/pBAD24, *Δfur*/pBAD24, or *ΔhlyU*/pBAD24, respectively ([@B43]). All the primers used are listed in **Table [1](#T1){ref-type="table"}**.

###### 

Oligonucleotide primers used in this study.

  Target                                 Primers (forward/reverse, 5'-3')
  -------------------------------------- ------------------------------------------------------------------------------
  Construction of mutants                
  *hapR*                                 GCGGGATCCCCAGCAATACATCTTTACC/GTGCTGCCCAAGAAAAGGGGTATATCCTTGCC
                                         GGCAAGGATATACCCCTTTTCTTGGGCAGCAC/GCGACTAGTAACTCACCAAAACCTTC
                                         GCGGGATCCCCAGCAATACATCTTTACC/GCGACTAGTAACTCACCAAAACCTTC
  *fur*                                  CGGGATCCTTCGTGTAAGGCAGCAGTAATC/CAGAGCGTAAAGCCTATGGATACTTTCCTGTTGATGTTC
                                         GAACATCAACAGGAAAGTATCCATAGGCTTTACGCTCTG/GGACTAGTAGATGAAGATGGTGTGGGAAAC
                                         CGGGATCCTTCGTGTAAGGCAGCAGTAATC/GGACTAGTAGATGAAGATGGTGTGGGAAAC
  *hlyU*                                 GCGGGATCCCCAGGCAGTCGAACCGCA/TACCTTTTTTTCGACCACCTTTAATTCCAACCCATTCATTC
                                         GAATGAATGGGTTGGAATTAAAGGTGGTCGAAAAAAAGGTA/GGACTAGTGAAAGGATAAGAATGTCATAG
                                         GCGGGATCCCCAGGCAGTCGAACCGCA/GGACTAGTGAAAGGATAAGAATGTCATAG
  Construction of complemented mutants   
  *hapR*                                 GATTCTAGAAGGAGGAATTCACCATGGACGCATCAATCGAAAAAC/GCGAAGCTTCTAGTTCTTATAGATACACAG
  *fur*                                  GATTCTAGAAGGAGGAATTCACCATGTCAGACAATAACCAAG/GCGAAGCTTTTATTTCTTCGGCTTGTGAG
  *hlyU*                                 GATTCTAGAAGGAGGAATTCACCATGCCGTATTTAAAGG/GCGAAGCTTCTACTGATTCGCCTGAC
  Protein expression                     
  *hapR*                                 GCGGGATCCATGGACGCATCAATCGAAAAAC/GCGAAGCTTCTAGTTCTTATAGATACACAG
  *fur*                                  GCGGGATCCATGTCAGACAATAACCAAG/GCGAAGCTTTTATTTCTTCGGCTTGTGAG
  *hlyU*                                 GCGGGATCCATGCCGTATTTAAAGG/GCGAAGCTTCTACTGATTCGCCTGAC
  qRT-PCR                                
  *hapR*                                 AAACGCAAACTACAACTGATGG/AGCACATCGTCAACCAAGTC
  *fur*                                  AGCCAGAGTGCCAACATATTAG/AATACTGACTTGCCGCCTTC
  *hlyU*                                 CTCAGCCAATCTGCTCTT/AGTTCAATCATCGCCTTC
  *hlyA*                                 CGTTAGATGCCTATTTCCG/CTCCACTGACTTCCACCC
  Luminescence assay                     
  *hapR*                                 GCGGAGCTCCCAGCAATACATCTTTACC/GCGACTAGTTGAGGCGATAGCCGAGTT
  *fur*                                  GCGGAGCTCGCATCAAGGCATAAACGG/GCGACTAGTATACTTTCCTGTTGATGTTC
  *hlyU*                                 GCGGAGCTCTGTTAGTTCCAGGCAGTC/GCGACTAGTTTTAATTCCAACCCATTC
  *hlyA*                                 GCGGAGCTCCAATCTATGCTTATACGG/GCGACTAGTGCAACGATTGAGTTTTGG
  Primer extension                       
  *hlyU*                                 /TTTGCAGTCGCCGCTCATTG
  *hlyA*                                 /TCATGGGTTACCCTCGTC
  DNase I footprinting                   
  *fur*                                  GTAAAACGACGGCCAGTGCATCAAGGCATAAACGG/CAGGAAACAGCTATGACGAGGCAAATCACTGAACAAA
  *hlyU*                                 GTAAAACGACGGCCAGTCGTGTTTATGGCTCCCTC/CAGGAAACAGCTATGACGATGTCGTAATTCGGTTG
  *hlyA*                                 GTAAAACGACGGCCAGTCTTATGTGTAAGCGTATTG/CAGGAAACAGCTATGACCGGATCACAGATTTTAGC
  *M13*                                  (FAM)GTAAAACGACGGCCAGT/(HEX)CAGGAAACAGCTATGAC

Growth Conditions
-----------------

The LB broth (1% tryptone, 0.5% yeast extract, and 1% NaCl) was used for *V. cholerae* cultivation. Overnight bacterial cultures were diluted 1:50 into 15 ml of fresh LB broth, and grown under 37°C with shaking at 200 rpm to reach an OD~600~ value of 1.0, and then diluted 1:100 into 15 ml of fresh LB broth for the third-round growth, and were harvested at required cell densities. When necessary, the LB broth was supplemented with 100 μg/ml ampicillin, 5 μg/ml chloramphenicol, 100 μg/ml kanamycin, or 0.1% arabinose.

Hemolytic Activity Assay
------------------------

The hemolytic activity of *V. cholerae* strains were tested using the method previously described with slight modifications ([@B59]); 5 μl of the third-round bacterial cultures were transferred onto LB agar containing 5% sheep blood erythrocytes, 100 μg/ml ampicillin, and 0.1% arabinose. The LB blood plates were incubated at 37°C for 20 h.

Luminescence Assay
------------------

For the *lux* activity assay ([@B54]), the promoter DNA region of each target gene was PCR amplified and cloned into the corresponding restriction endonuclease sites of pBBRlux vector harboring a promoterless *luxCDABE* reporter gene and a chloramphenicol resistance gene. The resulting plasmid was then transferred into WT and mutant strains, respectively. The *V. cholerae* strains transformed with recombinant plasmids were cultivated completely in LB broth at 37°C, and harvested at the required cell densities. The luminescence was measured using an Infinite^®^ 200 Pro NanoQuant (Tecan, Switzerland). The *lux* activity was calculated as light units/OD~600~.

RNA Isolation and Quantitative Real-Time PCR (qRT-PCR)
------------------------------------------------------

Total RNAs were extracted using the TRIzol Reagent (Invitrogen, United States). The cDNAs were generated by using 12 μg of total RNAs and 3 μg of random hexamer primers. The quantitative real-time PCR (qRT-PCR) assay was performed and analyzed as previously described ([@B16]). The relative mRNA levels were determined based on the standard curve of *recA* (reference gene) expression for each RNA preparation.

Preparation of 6× His-Tagged Proteins
-------------------------------------

The entire coding region of *hapR, fur*, and *hlyU* was amplified and cloned into the plasmid pET28a (Novagen, United States), respectively. The resulting plasmids encoding His-tagged proteins were transferred into *Escherichia coli* BL21λDE3 cells for protein expression ([@B25]). The methods for purification of His-tagged proteins were done as previously described ([@B17]; [@B58]). The eluted His-tagged proteins were dialyzed and then concentrated to a final concentration of 0.3--0.6 mg/ml. The purity of purified proteins was analyzed by SDS-PAGE.

DNase I Footprinting
--------------------

The procedures for DNase I footprinting assay and DNA sequencing were carried out as previously described ([@B15]; [@B36]; [@B59]). Briefly, upon being incubated with the increasing amounts of His-tagged protein, the FAM (or HEX)-labeled DNA probes were digested by the optimized RQ1 RNase-Free DNase I (Promega). The digested DNA fragments were then analyzed using an ABI 3500XL DNA Genetic analyzer with GeneMarker software 2.2, while the DNA sequencing products were surveyed with Sequence Scanner software v1.0.

Primer Extension Assay
----------------------

The primer extension assay was performed as previously described with slight modifications ([@B16]). Briefly, 12 μg of total RNA was annealed with 1 pmol of 5′-HEX-labeled reverse oligonucleotide primer to generate cDNAs using the Primer Extension System (Promega) according to the manufacturer's instructions. The primer extension products and sequencing materials were analyzed using the same methods as that of the DNase I footprinting assay.

Experimental Replicates and Statistical Methods
-----------------------------------------------

The presented data of hemolytic activity assay, DNase I footprinting, and primer extension were done at least two independent times. The luminescence assay and qRT-PCR were performed with at least three independent bacterial cultures, and the values were expressed as the mean ± SD. Paired Student's *t-*test was used to calculate statistically significant differences, and *p* \< 0.01 was considered to indicate statistical significance.

Results
=======

HapR and Fur Represses the Hemolytic Activity of *Vibrio cholerae*
------------------------------------------------------------------

The hemolytic activities against sheep blood erythrocytes were compared between WT/pBAD24, mutant (*ΔhapR*/pBAD24, *Δfur*/pBAD24, or *ΔhlyU*/pBAD24), and the complementary mutant (*ΔhapR*/pBAD24-*hapR, Δfur*/pBAD24-*fur*, or *ΔhlyU*/ pBAD24-*hlyU*) strains (**Figure [1](#F1){ref-type="fig"}**). The results showed that the WT/pBAD24 and all of the complementary mutants exhibit α-type hemolysis, but *ΔhapR*/pBAD24 and *Δfur*/pBAD24 manifest β-type hemolysis. Thus, both HapR and Fur strongly inhibited the hemolytic activity of *V. cholerae*. Although the *ΔhlyU*/pBAD24 strain also exhibited α-type hemolysis, its colony was much dull than that of WT/pBAD24 or *ΔhlyU*/pBAD24-*hlyU*, which is consistent with HlyU activation of *hlyA* transcription. Taken together, these results indicated that the transcription of *hlyA* would be under the negative control of HapR and Fur, but under the positive regulation of HlyU.

![Hemolytic activity of different *Vibrio cholerae* strains on LB-5% sheep blood agar. After being incubated at 37°C for 48 h, the LB blood plates were photographed. I, II, III, IV, V, VI, and VII represent WT/pBAD24, *ΔhlyU*/pBAD24, *ΔhlyU*/pBAD24-*hlyU, ΔhapR*/pBAD24, *ΔhapR*/pBAD24-*hapR, Δfur*/pBAD24, and *Δfur/*pBAD24-*fur*, respectively.](fmicb-09-01310-g001){#F1}

Transcription of *hapR, fur, hlyU*, and *hlyA* Were All Cell Density-Dependent
------------------------------------------------------------------------------

The luminescence reporter assay was employed to measure the transcription changes of *hapR, fur, hlyU*, and *hlyA* during the growth periods of the strains (**Figure [2](#F2){ref-type="fig"}**). The transcription levels of all of the four genes were increased but then reduced with the increase of cell density. In addition, the transcriptional activity of each of the four genes could be detected at all cell densities. However, the highest transcription of *hapR* occurred at an OD~600~ value of around 1.0, while that of *fur, hlyU*, and *hlyA* appeared at an OD~600~ value of around 0.6--0.7. Thus, the *V. cholerae* cells were harvested at the OD~600~ value of about 1.0 and 0.6 for characterizing HapR- and Fur/HlyU-mediated gene regulation, respectively. Moreover, the cell density-dependent transcription of *fur* and *hlyU* suggests that their expression would be under the control of QS.

![Cell density-dependent expression of target genes. The promoter DNA region of each target gene was cloned into the pBBRlux vector and then transferred into WT to determine the luminescence activity under various OD~600~ values. The bacteria were cultivated completely in LB broth containing the appropriate antibiotics and grown with shaking at 37°C.](fmicb-09-01310-g002){#F2}

HlyU Activates *hlyA* Transcription but Represses Its Own Gene
--------------------------------------------------------------

As determined by the luminescence assay (**Figure [3A](#F3){ref-type="fig"}**), the promoter activity of *hlyA* in *ΔhlyU* was much lower relative to that in WT, whereas that of luminescence under the control of *hlyU* promoter in *ΔhlyU* was much higher than that in WT, suggesting the positive and negative regulation of *hlyA* and *hlyU* by HlyU, respectively. The qRT-PCR assay further confirmed the positive correlation between HlyU and *hlyA* transcription in *V. cholerae* (**Figure [3B](#F3){ref-type="fig"}**). The DNase I footprinting assay showed that His-HlyU protected a single region, i.e., --563\...--627 or --99\...--155, for *hlyA* or *hlyU* promoter, respectively, against DNase I digestion in a dose-dependent manner (**Figure [3C](#F3){ref-type="fig"}**). Taken together, these results suggested that HlyU acts as a transcriptional activator of *hlyA* but serves as a repressor of its own gene in *V. cholerae*.

![Regulation of *hlyU* and *hlyA* by HlyU. The luminescence assay **(A)** was done as **Figure [2](#F2){ref-type="fig"}**. **(B)** qRT-PCR. The relative mRNA level of *fur* was compared between *ΔhlyU* and WT. **(C)** DNase I footprinting. The promoter fragment of each target gene was labeled with FAM or HEX, incubated with increasing amounts of purified His-HlyU (Lanes-I, II, and III contain 0, 4.06, and 12.12 pmol, respectively), and then subjected to DNase I footprinting assay. The results were analyzed using an ABI 3500XL DNA analyzer. The protected regions are boxed and marked with positions. The negative and positive numbers indicate the nucleotide positions relative to the translation start site (+1) of each target genes, respectively.](fmicb-09-01310-g003){#F3}

Negative Regulatory Actions of HapR and Fur on *hlyU* and *hlyA*
----------------------------------------------------------------

The results of luminescence assay showed that the promoter activities of *hlyU* and *hlyA* in both *ΔhapR* and *Δfur* were much higher relative to that in WT (**Figures [4A](#F4){ref-type="fig"}, [5A](#F5){ref-type="fig"}**). The qRT-PCR assay indicated that the transcriptional levels of *hlyU* and *hlyA* significantly increased in *ΔhapR* and *Δfur* relative to WT (**Figures [4B](#F4){ref-type="fig"}, [5B](#F5){ref-type="fig"}**). The DNase I footprinting assay disclosed that His-HapR protected two different DNA regions for each promoter against DNase I digestion (**Figure [4C](#F4){ref-type="fig"}**), while His-Fur only protected a single region for each promoter (**Figure [5C](#F5){ref-type="fig"}**). Taken together, both HapR and Fur repressed the transcription of *hlyU* and *hlyA* in a direct manner.

![Negatively regulation of *hlyU* and *hlyA* by HapR. The luminescence assay **(A)** was done as **Figure [2](#F2){ref-type="fig"}**. The qRT-PCR **(B)** and DNase I footprinting assay **(C)** were done as **Figure [3](#F3){ref-type="fig"}**. Lanes-I, II, and III contain 0, 2.31, and 6.92 pmol His-HapR, respectively.](fmicb-09-01310-g004){#F4}

![Negatively regulation of *hlyU* and *hlyA* by Fur. The luminescence assay **(A)** was done as **Figure [2](#F2){ref-type="fig"}**. The qRT-PCR **(B)** and DNase I footprinting assay **(C)** were done as **Figure [3](#F3){ref-type="fig"}**. Lanes-I, II, and III contain 0, 2.95, and 8.85 pmol His-Fur, respectively.](fmicb-09-01310-g005){#F5}

Identification of the Transcription Start Sites for *hlyA* and *hlyU*
---------------------------------------------------------------------

Two transcriptions start sites of *fur* have been previously reported in *V. cholerae* (also seen in **Figure [8](#F8){ref-type="fig"}**; [@B29]; [@B27]). In the present work, the primer extension assay was employed to map the transcription start sites of *hlyA* and *hlyU*. The assay detected only one transcription start site for each gene located at 287 bp upstream of *hlyA* and 432 bp upstream of *hlyU*, respectively (**Figure [6](#F6){ref-type="fig"}**).

![Transcription start sites of *hlyA* and *hlyU*. A 5'-HEX-labeled oligonucleotide primer was designed to be complementary to the RNA transcript of each target gene. The primer extension products were analyzed with an ABI 3500XL DNA Genetic analyzer. The transcription start sites are marked with asterisks and positions.](fmicb-09-01310-g006){#F6}

HapR Represses *fur* Transcription
----------------------------------

The recombinant pBBRlux plasmid that contains the promoter-proximal region of *fur* and a promoterless *luxCDABE* reporter gene was transferred into *ΔhapR* and WT, respectively, to test the action of HapR on the promoter activity of *fur*. As shown in **Figure [7A](#F7){ref-type="fig"}**, the promoter activity of *fur* in *ΔhapR* was much higher relative to that in WT, indicating the negative correlation of HapR and *fur* transcription in *V. cholerae*. As further determined by the qRT-PCR assay (**Figure [7B](#F7){ref-type="fig"}**), the mRNA level of *fur* was significantly enhanced in *ΔhapR* relative to WT. The results of *in vitro* DNase I footprinting (**Figure [7C](#F7){ref-type="fig"}**) demonstrated that His-HapR protected a single region from 238 to 558 bp upstream of *fur* against DNase I digestion in a dose-dependent manner. Taken together, HapR directly and negatively regulates the transcription of *fur* in *V. cholerae*.

![Transcription of *fur* was negatively regulated by HapR. The luminescence assay **(A)** was done as **Figure [2](#F2){ref-type="fig"}**. The qRT-PCR **(B)** and DNase I footprinting assay **(C)** were done as **Figure [3](#F3){ref-type="fig"}**.](fmicb-09-01310-g007){#F7}

Discussion
==========

Although iron-, Fur-, HapR-, and HlyU-dependent expression of *hlyA* has been previously reported in *V. cholerae* ([@B42]; [@B50]; [@B45]; [@B33]), the detailed regulatory mechanisms need to be further illustrated. In this study, we showed that the transcription of *hlyA* was regulated coordinately by HlyU, HapR, and Fur in *V. cholerae* El Tor biotype (**Figure [8](#F8){ref-type="fig"}**). At the late mid-logarithmic growth phase (OD~600~ ≈ 1.0), the highly expressed HapR bound to the promoters of *fur, hlyU*, and *hlyA* to repress their transcription. At the early mid-logarithmic growth phase (OD~600~ ≈ 0.6), the highly expressed Fur bounds to the promoters of *hlyU* and *hlyA* to repress their transcription; meanwhile, HlyU bounds to the promoters of *hlyA* and *hlyU* to activate and inhibit their transcription, respectively. The highest transcriptional level of *hlyA* occurred at an OD~600~ value of about 0.7 due to the tight regulation of HapR, Fur, and HlyU, suggesting that HlyA would function at the early mid-logarithmic growth phase in *V. cholerae*.

![Regulatory circuit. The regulatory actions between LuxO, Qrr sRNAs, AphA, and HapR were previously described in *Vibrio cholerae* and closely related vibrios ([@B20]; [@B46]; [@B37]; [@B44]; [@B58]). AphA and HapR are the two master QS regulators operating at LCD and HCD, respectively. Fur and HlyU, which are transcribed highly at an OD~600~ value of around 0.6, coordinate with HapR to tightly regulate *hlyA* transcription, leading to the high expression of HlyA at the early mid-logarithmic growth phase. Positive autoregulation of Fur has been established in *V. vulnificus* ([@B28]); this mechanism would be conserved between *V. vulnificus* and *Vibrio cholerae*.](fmicb-09-01310-g008){#F8}

*Vibrio vulnificus* secretes a potent hemolysin (VvhA) sharing homologous regions with HlyA ([@B56]). VvhA exhibits strongly cytolytic and hemolytic activities and may contribute to the bacterial invasion and causes vasodilatation ([@B23]; [@B26]; [@B12]). *Vibrio vulnificus* SmcR, a HapR homolog, directly represses the expression of *hlyU* and *vvhA*, while HlyU directly activates *vvhA* transcription ([@B40]; [@B49]). Deletion of *hlyU* resulted in the loss of cytotoxicity and reduced VvhA production in the *smcR* mutant ([@B40]). The double mutant of *smcR* and *hlyU* regained cytotoxicity and hemolytic activity when *hns* was further deleted ([@B40]). HlyU seems act as an anti-repressor of H-NS in the regulation of the virulence genes in *V. vulnificus* ([@B30]). In addition, it has been shown that iron represses *vvhA* transcription via Fur, which represses *vvsA* transcription in the presence of iron through the protein--promoter DNA association ([@B22]). The binding site of Fur overlaps with that of SmcR but with a higher affinity than SmcR ([@B49]). Moreover, Fur has been shown to be involved in the regulation of *smcR* transcription in *V. vulnificus* ([@B24]; [@B48]). However, *V. cholerae* Fur seems to have no regulatory activity on *hapR* transcription (data not shown), suggesting that the regulation of the QS regulator gene by Fur may depend on the bacterial growth conditions. Nevertheless, the conservative regulatory mechanisms might be employed to tightly control of the HlyA production in *V. vulnificus* and *V. cholerae*.

The transcription of *hlyA, fur*, and *hlyU* was stimulated at the early mid-logarithmic growth phase but repressed at both low cell density (LCD) and high cell density (HCD; **Figure [2](#F2){ref-type="fig"}**), suggesting that some unknown regulators can repress their transcription at LCD. AphA has been considered as the bottom master regulator of QS operating at LCD ([@B34]; [@B2]). The DNA binding box of AphA has been identified as an inverted repeat of ATATGC with a 6-nt centered spacer, i.e., ATATGCA-N6-TGCATAT ([@B44]). An AphA box-like sequence (ATACTCCTCTTTAATCTCAT) was detected within the promoter of *hlyU* but was not found in the other two promoters (**Figure [9](#F9){ref-type="fig"}**). Thus, the transcription of *hlyU* would be under the direct control of AphA. The asymmetric production of AphA and HapR orthologs coupled with their combined inhibition of downstream targets has been observed in other vibrios ([@B47]; [@B57]). For example, in *Vibrio harveyi*, both AphA and LuxR bound to the promoters of the type III secretion system (T3SS) genes to repress their transcription, resulting in the highest expression levels of T3SS occurring at LCD-to-HCD transition ([@B47]); in *Vibrio parahaemolyticus*, ToxR coordinates with AphA and OpaR to repress T6SS1, leading to the highest expression of T6SS1 occurring at the mid-logarithmic growth phase ([@B57]). However, the detailed regulatory mechanisms of AphA or other additional factors on *hlyA* transcription in *V. cholerae* need to be further investigated.

![Structural organization of target promoters. The DNA sequence was derived from *Vibrio cholerae* El Tor C7258. The transcription/translation start sites are indicated by bent arrows. Shine-Dalgarno (SD) box and --10/--35 elements are enclosed in boxes. The HapR sites are underlined with broken lines, the Fur sites are underlined with solid lines, while the HlyU sites are underlined with dotted lines.](fmicb-09-01310-g009){#F9}

The organization of *fur, hlyU*, and *hlyA* promoters was reconstructed herein, by collecting the data of translation/transcription start sites, promoter -10 and -35 elements, HapR/Fur/HlyU binding sites, AphA box-like sequence, and Shine-Dalgarno (SD) sequences (ribosomal binding sites; **Figure [9](#F9){ref-type="fig"}**). One HapR binding site was detected in the upstream of *fur* and *hlyA*, respectively, and each overlaps the core -10 element; two HapR binding sites for *hlyU* were detected and both of them were located downstream of the transcription start site. Thus, the binding of HapR would block the entry or elongation of the RNA polymerase to repress the transcription of the target genes. Both the Fur and HlyU sites for *hlyU* are located downstream of the transcription start site, indicating that the repression mechanisms of *hlyU* by Fur and HlyU would be similar to that by HapR. Notably, the Fur site for *hlyU* overlaps the HapR site 1, while HlyU site overlaps the HapR site 2. Thus, there may be a competitive binding activity between HapR and Fur or HlyA in the binding of the *hlyU* promoter. Although the binding site of Fur to *hlyA* is located upstream of the transcription start site, it overlaps with that of HlyU. Thus, the binding of HapR would block the binding of HlyU, which acts as a transcriptional activator of *hlyA* in *V. cholerae*.

Conclusion
==========

This work reports that QS coordinates with HlyU and Fur to regulate *hlyA* transcription in *V. cholerae*, leading to the highest transcription of *hlyA* occurring at the early mid-logarithmic growth phase when bacteria cells are grown in LB broth. Therefore, we propose that at the early or middle stage of infection, *V. cholerae* produces high amount of HlyA in the small intestine, which promotes the bacterial invasion and pathogenesis, and contributes to the watery diarrhea; at the end of the infectious cycle, since HapR is highly expressed, it activates the protease production and inhibits the biofilm formation, to detach the mutual aggregation of *V. cholerae* cells in the initial infection sites in the intestine. Meanwhile, the expression of CT decreases, and therefore the shift to lower expression of HlyA may have a similar response of CT.
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